RSR Limited
Registered name: RSR LIMITED
Part of Dixondale Limited groupRSR Limited made £22.2m revenue and £17.7m profit in the year to 30 Sep 2023.
RSR Limited’s revenue fell 9% to £22.2m in the year to 30 Sep 2023, with £17.7m profit and 96 employees. The company is classified under “manufacture of basic pharmaceutical products” and is based in Lancaster; we hold 2 years of its filed accounts.
- Status
- Active
- Location
- Lancaster, North West
- Age
- 27 yrs · since 1999
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently.
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 30 Sep 2022 | 30 Sep 2023 |
|---|---|---|
| Disclosure | Full P&L | Full P&L |
| Profit & loss | ||
| Revenue (turnover) | £24.4m | £22.2m |
| Cost of sales | £6.3m | £10m |
| Gross profit | £18.1m | £12.2m |
| Operating profit | £25.4m | £19.4m |
| Profit before tax | £25.5m | £19.5m |
| Profit after tax | £22m | £17.7m |
| Profit (best available) | £22m | £17.7m |
| Staff costs | £5.8m | £6.1m |
| Employees (average) | 99 | 96 |
| Ratios | ||
| Profit margin | 90.1% | 79.6% |
| Gross margin | 74% | 55% |
| Revenue per employee | £246k | £231k |
| Profit per employee | £222k | £184k |
| Cash conversion | −98.8% | −89.1% |
| Growth (year on year) | ||
| Revenue growth | — | ▼9.1% |
| Profit growth | — | ▼19.7% |
| Headcount growth | — | ▼3% |
| Balance sheet — indirect signals, not revenue | ||
| Cash at bank | £23.3m | £19.6m |
| Net assets | £31.6m | £32.3m |
| Fixed assets | £409k | £297k |
| Current assets | £33.3m | £33.1m |
| Debtors | £4.3m | £4m |
| Cash from operations | −£25.1m | −£17.3m |
| Source | FullAccounts · bulk data Jun 2024 | FullAccounts · bulk data Jun 2024 |
How the business works
- Profit margin
- 79.6%
- Profit ÷ revenue.
- Gross margin
- 55%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £231k
- Revenue ÷ average employees.
- Profit per employee
- £184k
- Profit ÷ average employees.
- Cash conversion
- −89.1%
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 1.3%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 17.8%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲2%
- Now £32.3m
- Cash at bank
- ▼16%
- Now £19.6m
- Headcount
- ▼3%
- Now 96
- Deferred income
- —
- Now —
- Fixed assets
- ▼27%
- Now £297k
Group structure
Ownership chain
- Dixondale Limitedultimate parent75–100%
- RSR Limitedthis company
Bands show the share of ownership each company holds in the one below it.
Subsidiaries (1)
- AV7 LimitedRev. £0 · Profit −£398k
Sister companies (1)
- Lotein LimitedRev. £188k · Profit £113k
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Specialist Anodising Company LimitedChester · Manufacture of basic pharmaceutical products
- Revenue
- £23.1m
- Profit
- £3.2m
- Staff
- 326
- Diomed Developments LimitedLoughton · Manufacture of basic pharmaceutical products
- Revenue
- £21.2m
- Profit
- £2.8m
- Staff
- 6
- Parkacre LimitedGainsborough · Manufacture of basic pharmaceutical products
- Revenue
- £26.1m
- Profit
- £904k
- Staff
- 182
- Principle Healthcare LimitedLeeds · Manufacture of basic pharmaceutical products
- Revenue
- £18.5m
- Profit
- £702k
- Staff
- 16
- G.R. Lane Health Products LimitedGloucester · Manufacture of basic pharmaceutical products
- Revenue
- £26.8m
- Profit
- £334k
- Staff
- 180
- Milton-Lloyd LimitedManufacture of basic pharmaceutical products
- Revenue
- £16.9m
- Profit
- £218k
- Staff
- 19
Sources
Latest figures from FullAccounts for the year to 30 Sep 2023 (profit £17.7m), from the Companies House accounts bulk data published Jun 2024. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.